PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.06
0.06 - 0.24
2.78M / 3.59M (Avg.)
-1.55 | -0.04
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-0.53
Both companies show losses. Martin Whitman would check if industry conditions create special situations.
0.67
P/S less than half of CRN.AX's 1.70. Joel Greenblatt would verify if margins support this discount.
-3.43
Negative equity while CRN.AX shows P/B of 0.90. Joel Greenblatt would examine balance sheet repair potential.
-3.38
Negative FCF while CRN.AX shows P/FCF of 32.85. Joel Greenblatt would examine cash flow improvement potential.
-3.90
Negative operating cash flow while CRN.AX shows P/OCF of 13.97. Joel Greenblatt would examine operational improvement potential.
-3.43
Negative fair value while CRN.AX shows ratio of 0.90. Joel Greenblatt would examine valuation model differences.
-47.13%
Both companies show losses. Martin Whitman would check for industry-wide issues.
-29.62%
Negative FCF while CRN.AX shows yield of 3.04%. Joel Greenblatt would examine cash flow improvement potential.